Company: OSRH
Filing Date: 2025-11-25
Form Type: 8-K
Source: 0001213900-25-114496
Chunk: 2

Company: OSR Holdings, Inc.
Filing Date: 2025-11-25
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01. Financial Statements and Exhibits

(d) Exhibits

EXHIBIT INDEX

  Exhibit No.      Description                                                                                                                                                                                
         10.1      Global License Agreement Term Sheet, dated November 21, 2025, between Vaximm AG and BCM Europe AG                                                                                          
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
         99.1      Press Release dated November 21, 2025 titled “ Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones.”  
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                                                

SIGNATURE

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 25, 2025

  OSR HOLDINGS, INC.                                                    
  By:                     /s/                                           
                          Name:                Kuk Hyoun Hwang          
                          Title:               Chief Executive Officer